Golden State Medical Supply recalls Carbamazepine 200mg tablets with black specks
Golden State Medical Supply recalls 200mg carbamazepine tablets with black specks due to CGMP deviations. Patients should contact their doctor for guidance.
Lower-risk recall
CGMP deviations: tablets with black specks.
What happened, in plain English
Golden State Medical Supply is recalling 200mg carbamazepine tablets that may contain black specks due to manufacturing issues. This could affect patients taking the medication, as the specks might indicate a quality problem. Read more at govinfonow.com/recall/692851-golden-state-medical-supply-recalls-carbamazepine-200mg-tablets-with-black.
Source Summary by GovInfoNow · govinfonow.com/recall/692851-golden-state-medical-supply-recalls-carbamazepine-200mg-tablets-with-black · Updated September 14, 2026 · FDA enforcement record: FDA #D-0771-2026
Cite this page
“Golden State Medical Supply recalls Carbamazepine 200mg tablets with black specks.” GovInfoNow, updated September 14, 2026. https://govinfonow.com/recall/692851-golden-state-medical-supply-recalls-carbamazepine-200mg-tablets-with-black. Based on FDA recall #D-0771-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0771-2026%22&limit=1).
Why it’s dangerous
The tablets may contain black specks due to CGMP deviations. This could indicate a quality issue that might affect the medication's safety or effectiveness.
Who’s affected
Patients prescribed carbamazepine tablets by a doctor. Those using the recalled products are most at risk.
How to tell if you have this one
Check for 200mg carbamazepine tablets in 1000-count or 100-count bottles with NDC numbers 51407-215-10 or 51407-215-01. The lot numbers are GS067429, GS068091, or GS067430, GS068090.
- Brand
Golden State Medical Supply- Category
Drug
What to do — step by step
Contact Your Doctor
Talk to your healthcare provider about the recalled medication and possible alternatives.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 19 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Golden State Medical Supply recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0771-2026 (August 7, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0771-2026 to see it in context.
- Plain-language summary written by qwen3:4b on September 14, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.